StockData
Herbalife Ltd. logo

Herbalife Ltd. (HLF) stock

HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 9/3042% below fair value
$16.04+0.47 (+3.02%)

Close on Nov 18, 2026Market cap $1.68BP/E 10.3Yield –

Herbalife cash

Cash and short-term investments held at the end of each period.

Herbalife's cash was $370.50M at Jun 30, 2026. For fiscal 2025 it was $353.10M, down 19.4% from the year before. Over ten years it grew -9.0% a year on average. The highest annual figure on record is $1.30B in fiscal 2017.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$353.10M-19.4%
FY2024Dec 31, 2024$438.10M-26.4%
FY2023Dec 31, 2023$595.50M+15.3%
FY2022Dec 31, 2022$516.30M-15.4%
FY2021Dec 31, 2021$610.40M-42.1%
FY2020Dec 31, 2020$1.05B+24.4%
FY2019Dec 31, 2019$847.50M-30.2%
FY2018Dec 31, 2018$1.22B-6.2%
FY2017Dec 31, 2017$1.30B+51.2%
FY2016Dec 31, 2016$856.90M-5.3%
FY2015Dec 31, 2015$904.40M+40.1%
FY2014Dec 31, 2014$645.40M-33.7%
FY2013Dec 31, 2013$973.00M+191.8%
FY2012Dec 31, 2012$333.50M+28.9%
FY2011Dec 31, 2011$258.80M+35.8%
FY2010Dec 31, 2010$190.55M+26.4%
FY2009Dec 31, 2009$150.80M-0.0%
FY2008Dec 31, 2008$150.85M-19.5%
FY2007Dec 31, 2007$187.41M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$370.50M+7.8%
Q1 FY2026Mar 31, 2026$451.20M+28.5%
Q4 FY2025Dec 31, 2025$353.10M-19.4%
Q3 FY2025Sep 30, 2025$305.50M-26.9%
Q2 FY2025Jun 30, 2025$343.60M-11.7%
Q1 FY2025Mar 31, 2025$351.00M-14.9%
Q4 FY2024Dec 31, 2024$438.10M-26.4%
Q3 FY2024Sep 30, 2024$417.90M-19.0%
Q2 FY2024Jun 30, 2024$389.30M-28.9%
Q1 FY2024Mar 31, 2024$412.50M-10.7%
Q4 FY2023Dec 31, 2023$595.50M+15.3%
Q3 FY2023Sep 30, 2023$516.00M-4.6%
Q2 FY2023Jun 30, 2023$547.30M-7.2%
Q1 FY2023Mar 31, 2023$461.80M-20.2%
Q4 FY2022Dec 31, 2022$516.30M-15.4%
Q3 FY2022Sep 30, 2022$540.70M-21.3%
Q2 FY2022Jun 30, 2022$589.90M-30.3%
Q1 FY2022Mar 31, 2022$578.60M-6.7%
Q4 FY2021Dec 31, 2021$610.40M-42.1%
Q3 FY2021Sep 30, 2021$687.00M-34.1%
Q2 FY2021Jun 30, 2021$846.30M-51.6%
Q1 FY2021Mar 31, 2021$620.30M-34.8%
Q4 FY2020Dec 31, 2020$1.05B+24.4%
Q3 FY2020Sep 30, 2020$1.04B+44.2%
Q2 FY2020Jun 30, 2020$1.75B+38.5%
Q1 FY2020Mar 31, 2020$952.10M-21.9%
Q4 FY2019Dec 31, 2019$847.50M-30.2%
Q3 FY2019Sep 30, 2019$723.20M-35.8%
Q2 FY2019Jun 30, 2019$1.26B+47.6%
Q1 FY2019Mar 31, 2019$1.22B-9.5%
Q4 FY2018Dec 31, 2018$1.22B-6.2%
Q3 FY2018Sep 30, 2018$1.13B-31.9%
Q2 FY2018Jun 30, 2018$855.10M-47.8%
Q1 FY2018Mar 31, 2018$1.35B-25.1%
Q4 FY2017Dec 31, 2017$1.30B+51.2%
Q3 FY2017Sep 30, 2017$1.65B+109.7%
Q2 FY2017Jun 30, 2017$1.64B–
Q1 FY2017Mar 31, 2017$1.80B–
Q4 FY2016Dec 31, 2016$856.90M–
Q3 FY2016Sep 30, 2016$788.30M–

More Herbalife figures

See a number that looks wrong?